Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Person › Details

Walid Abi-Saab (Galapagos N.V. (Euronext + Nasdaq: GLPG))

Abi-Saab, Walid (Galapagos 201809 CMO)


Organisation Organisation Galapagos N.V. (Euronext + Nasdaq: GLPG)
  Group Galapagos (Group)
Products Product drug discovery services
  Product 2 clinical research
Document Source Galapagos N.V.. (9/11/18). "Press Release: Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints in First Phase 3 Study in Rheumatoid Arthritis". Foster City, CA & Mechelen.

Record changed: 2019-01-06


Picture [iito] – Putting Information into Context 600x60px

More documents for Walid Abi-Saab

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top